Cited by 37Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration MechanismsTrace Elements in Health

Minocycline Rescues from Zinc-Induced Nigrostriatal Dopaminergic Neurodegeneration: Biochemical and Molecular Interventions

Kumar, Vinod, Singh, Brajesh Kumar, Chauhan, Amit Kumar, Singh, Deepali, Patel, Devendra Kumar, Singh, Chetna·2016·Molecular Neurobiology

Abstract

Accumulation of zinc (Zn) in dopaminergic neurons is implicated in Parkinson's disease (PD), and microglial activation plays a critical role in toxin-induced Parkinsonism. Oxidative stress is accused in Zn-induced dopaminergic neurodegeneration; however, its connection with microglial activation is still not known. This study was undertaken to elucidate the role and underlying mechanism of microglial activation in Zn-induced nigrostriatal dopaminergic neurodegeneration. Male Wistar rats were treated intraperitoneally with/without zinc sulphate (20 mg/kg) in the presence/absence of minocycline (30 mg/kg), a microglial activation inhibitor, for 2-12 weeks. While neurobehavioral and biochemical indexes of PD and number of dopaminergic neurons were reduced, the number of microglial cells was increased in the substantia nigra of the Zn-exposed animals. Similarly, Zn elevated lipid peroxidation (LPO) and activities of superoxide dismutase (SOD) and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase; however, catalase activity was reduced. Besides, Zn increased an association of NADPH oxidase subunit p67(phox) with membrane, cytochrome c release from the mitochondria and cleavage of pro-caspase 3. Zn attenuated the expression of tyrosine hydroxylase (TH) and vesicular monoamine transporter-2 (VMAT-2) while augmented the expression of dopamine transporter (DAT) and heme oxygenase-1 (HO-1). Minocycline alleviated Zn-induced behavioural impairments, loss of TH-positive neurons, activated microglial cells and biochemical indexes and modulated the expression of studied genes/proteins towards normalcy. The results demonstrate that minocycline reduces the number of activated microglial cells and oxidative stress, which rescue from Zn-induced changes in the expression of monoamine transporter and nigrostriatal dopaminergic neurodegeneration.

Integrity signals

Registry

Crossref · 10.1007/s12035-015-9137-y

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kumar, V., Singh, B. K., Chauhan, A. K., Singh, D., Patel, D. K., & Singh, C.
Affiliations
  • Council of Scientific and Industrial Research (IN)
  • Indian Institute of Toxicology Research (IN)
Corresponding author
Singh, Chetna
Venue
Molecular Neurobiology
Published
2015-03-13
Volume
53
Issue
5
Pages
2761-2777
ISSN
  • 0893-7648 (ISSN-L)
  • 1559-1182
OpenAlex
W2137385714
Cited by
37
References
40
Citations by year
2026: 2 · 2025: 3 · 2024: 1 · 2023: 4 · 2022: 6 · 2021: 6 · 2020: 5 · 2019: 1 · 2018: 1 · 2017: 5 · 2016: 2 · 2015: 1
FWCI
2.12
Type
journal article
Language
en
Open access
closed
Locations
  • Molecular Neurobiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
Keywords
minocycline, zinc neurotoxicity, Parkinson's disease, microglial activation, oxidative stress, lipid peroxidation, NADPH oxidase, p67phox, cytochrome c release, caspase-3, tyrosine hydroxylase, dopamine transporter, vesicular monoamine transporter 2, heme oxygenase-1, substantia nigra, neurobehavioral impairment
MeSH terms
Animals, Behavior, Animal, Dopamine, Gene Expression Regulation, Male, Minocycline, Mitochondria, Motor Activity, Nerve Degeneration, Nerve Tissue Proteins, Substantia Nigra, Tyrosine 3-Monooxygenase, Zinc, Lipid Peroxidation, Rats, Wistar, Microglia, Oxidative Stress, NADPH Oxidases, Membrane Transport Proteins, Antigens, Nuclear, CD11b Antigen, Cytochromes c, Rotarod Performance Test, Heme Oxygenase-1, Caspase 3, Metabolome, Dopaminergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review